Eli Lilly’s (LLY) Loxo and Foghorm (FHTX) Collaborate for Novel Oncology Targets using Foghorn’s Gene Traffic Control Platform
Go back to Eli Lilly’s (LLY) Loxo and Foghorm (FHTX) Collaborate for Novel Oncology Targets using Foghorn’s Gene Traffic Control Platform| (NASDAQ: FHTX) | Delayed: 4.18 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.18 | 52 Week High | $ | |||
| Open | $4.18 | 52 Week Low | $ | |||
| Day High | $4.18 | P/E | N/A | |||
| Day Low | $4.18 | EPS | $ | |||
| Volume | 4 | |||||
| Lilly (Eli) & Co. (NYSE: LLY) | Delayed: 1102.08 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1102.08 | 52 Week High | $88.16 | |||
| Open | $1102.08 | 52 Week Low | $67.88 | |||
| Day High | $1102.08 | P/E | 255.11 | |||
| Day Low | $1102.08 | EPS | $4.32 | |||
| Volume | 6,482 | |||||

